US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
Shipping box for Revvity reagent kits
The Human IL17A/IL17RA binding kit is designed to identify human IL17A/IL17RA inhibitors.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
| Sample Volume | 2 µL |
The Human IL17A/IL17RA binding kit is designed to identify human IL17A/IL17RA inhibitors.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Product Variants
Unit Size: 500 Assay Points
Part #:
64BDIL17PEG
List Price
USD 1,254.00
Unit Size: 10,000 Assay Points
Part #:
64BDIL17PEH
List Price
USD 15,010.00
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
Shipping box for Revvity reagent kits
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
Product information
Overview
Interleukin 17A, a pro-inflammatory cytokine, belongs to a family of six cytokines; IL-17A, IL-17B, IL-17C, IL-17D, IL-E, and IL-17F. IL-17A binds a heterodimeric cell surface receptor (IL-17RA/IL-17RC), triggering a signaling cascade that results in NF-κB activation which leads to the stimulation of the pro-inflammatory cytokines IL-6 and IL-8. Although this cytokine exerts a protective role against many pathogens, the overproduction of IL-17A is associated with autoimmune diseases such as psoriasis, rheumatid arthritis, and Crohn's Disease.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Brand |
HTRF
|
| Detection Modality |
HTRF
|
| Product Group |
Kit
|
| Sample Volume |
2 µL
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target Class |
Binding Assay
|
| Target Species |
Human
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Inflammation
|
| Unit Size |
10,000 Assay Points
|
Video gallery
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
HTRF Human IL-17A / IL17RA Binding Kit, 10,000 Assay Points
How it works
Assay principle
The HTRF IL17A/IL17RA Binding kit is designed to measure the interaction between IL17A and IL17RA proteins. Without treatment, IL17A binds to IL17RA, and the binding of each detection antibody to its respective tagged protein generates an HTRF signal. In the presence of a compound or an anti-human blocking antibody, the IL17A/IL17RA interaction is disrupted and the HTRF signal decreases.
Assay protocol
The Human IL17RA/IL17RA binding kit can be run in 96- or 384-well low volume white plates (20 µL final). As described here, samples or standards are dispensed directly into the assay plate. The Tag1-IL17A protein and Tag2-IL17RA proteins are then added, followed by the dispensing of the HTRF reagents: the anti Tag1 reagent labeled with europium cryptate and the anti Tag2 antibody labeled with XL665. The reagents labeled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
Assay validation
Inhibitory effects of IL17A/IL17RA blockers
The inhibitory effects of unlabeled IL17A and IL17R, and human anti-IL17A antibody, were tested. No inhibition was observed using an anti EGFR antibody (cetuximab), confirming the specificity of the kit for the study of IL17A/IL17RA interaction.
Resources
Are you looking for resources, click on the resource type to explore further.
Guide
HTRF solutions, guide to major applications
This guide provides you an overview of HTRF applications in several therapeutic areas.
How can we help you?
We are here to answer your questions.
